TONIX PHARMACEUTICALS HOLDING CORP. Shareholders' Equity
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Shareholders' Equity of $222.28 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $222.28M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $227.14M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $245.15M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $231.14M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $222.28M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $227.14M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $245.15M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $231.14M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $168.00M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $180.40M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $139.56M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $74.21M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $42.10M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $108.14M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $105.53M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $120.83M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $140.46M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $165.43M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $207.18M 10-K · filed 2025-03-18 | |
| 2022-09-30 | $228.92M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $228.28M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $207.96M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $218.72M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $202.22M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $180.49M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $176.92M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $87.65M 10-K · filed 2023-03-13 | |
| 2020-09-30 | $62.57M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $53.57M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $31.25M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $9.42M 10-K · filed 2022-03-14 | |
| 2019-09-30 | $9.86M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $12.82M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $17.81M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $23.66M 10-K · filed 2021-03-15 | |
| 2018-09-30 | $13.71M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $15.84M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $18.61M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $24.62M 10-K · filed 2020-03-24 | |
| 2017-09-30 | $28.68M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $33.97M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $21.98M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $25.36M 10-K · filed 2019-03-18 | |
| 2016-09-30 | $27.11M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $30.03M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $27.34M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $40.26M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $52.65M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $46.24M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $56.89M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $36.09M 10-K · filed 2017-04-13 | |
| 2014-09-30 | $43.78M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $42.66M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $47.92M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $6.51M 10-K · filed 2016-03-03 | |
| 2013-09-30 | $5.44M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$1.96M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$639.74K 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $959.00K 10-K · filed 2016-03-03 | $958.71K 10-K · filed 2013-03-11 |
| 2012-09-30 | -$674.34K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $714.89K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | -$378.89K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$2.45M 10-K · filed 2014-03-28 | -$2.45M 10-K · filed 2012-03-30 |
| 2011-09-30 | -$15.04K 10-Q · filed 2011-10-07 | |
| 2011-06-30 | -$12.71K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$175.00K 10-K · filed 2014-03-28 | -$5.68K 10-Q · filed 2011-08-15 |
| 2009-12-31 | -$537.00K 10-K · filed 2014-03-28 | -$537.44K 10-K · filed 2012-03-30 |
| 2008-12-31 | -$545.00K 10-K · filed 2014-03-28 | -$545.01K 10-K · filed 2012-03-30 |
| 2007-12-31 | -$415.00K 10-K · filed 2014-03-28 | -$415.31K 10-K · filed 2012-03-30 |
| 2007-06-07 | $0.00 10-K · filed 2014-03-28 | |
| 2007-06-06 | $0.00 10-K · filed 2013-03-11 | |
| 2007-05-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |